These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 37243580)

  • 1. A systematic review of commercial high concentration antibody drug products approved in the US: formulation composition, dosage form design and primary packaging considerations.
    Ghosh I; Gutka H; Krause ME; Clemens R; Kashi RS
    MAbs; 2023; 15(1):2205540. PubMed ID: 37243580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Product-Specific Impact of Viscosity Modulating Formulation Excipients During Ultra-High Concentration Biotherapeutics Drug Product Development.
    Rodrigues D; Tanenbaum LM; Thirumangalathu R; Somani S; Zhang K; Kumar V; Amin K; Thakkar SV
    J Pharm Sci; 2021 Mar; 110(3):1077-1082. PubMed ID: 33340533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Container Closure and Delivery Considerations for Intravitreal Drug Administration.
    Parenky AC; Wadhwa S; Chen HH; Bhalla AS; Graham KS; Shameem M
    AAPS PharmSciTech; 2021 Mar; 22(3):100. PubMed ID: 33709236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Analysis of Biopharmaceutical Products Listed in the FDA's Purple Book.
    Chen F; Zhong H; Chan G; Ouyang D
    AAPS PharmSciTech; 2024 Apr; 25(5):88. PubMed ID: 38637407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive Scientific Survey of Excipients Used in Currently Marketed, Therapeutic Biological Drug Products.
    Rao VA; Kim JJ; Patel DS; Rains K; Estoll CR
    Pharm Res; 2020 Sep; 37(10):200. PubMed ID: 32968854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of syringes and vials for delivery of biologics: current challenges and innovative solutions.
    Yoneda S; Torisu T; Uchiyama S
    Expert Opin Drug Deliv; 2021 Apr; 18(4):459-470. PubMed ID: 33217252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introducing the Alba® Primary Packaging Platform. Part 2: Inorganic Extractables Evaluation.
    Chillon A; Zuccato D
    PDA J Pharm Sci Technol; 2019; 73(3):235-246. PubMed ID: 30651335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Characterization of Antibody-Excipient Interactions for Rational Excipient Selection Using the Site Identification by Ligand Competitive Saturation-Biologics Approach.
    Jo S; Xu A; Curtis JE; Somani S; MacKerell AD
    Mol Pharm; 2020 Nov; 17(11):4323-4333. PubMed ID: 32965126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges for Cell-Based Medicinal Products From a Pharmaceutical Product Perspective.
    Jere D; Sediq AS; Huwyler J; Vollrath I; Kardorff M; Mahler HC
    J Pharm Sci; 2021 May; 110(5):1900-1908. PubMed ID: 33307042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filling of High-Concentration Monoclonal Antibody Formulations into Pre-filled Syringes: Investigating Formulation-Nozzle Interactions To Minimize Nozzle Clogging.
    Shieu W; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2015; 69(3):417-26. PubMed ID: 26048747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Packaging and labeling of pharmaceutical products obtained from the internet.
    Veronin M
    J Med Internet Res; 2011 Feb; 13(1):e22. PubMed ID: 21324833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Part II: Matrix based scaffold lyophilization facilitates processing as a prerequisite for an innovative packaging system.
    Kullmann D; Lema Martinez C; Lümkemann J; Huwyler J
    Eur J Pharm Biopharm; 2023 Mar; 184():262-273. PubMed ID: 36565968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Intercompany Perspective on Practical Experiences of Predicting, Optimizing and Analyzing High Concentration Biologic Therapeutic Formulations.
    Desai PG; Garidel P; Gbormittah FO; Kamen DE; Mills BJ; Narasimhan CN; Singh S; Stokes ESE; Walsh ER
    J Pharm Sci; 2023 Feb; 112(2):359-369. PubMed ID: 36442683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lyophilization of Small-Molecule Injectables: an Industry Perspective on Formulation Development, Process Optimization, Scale-Up Challenges, and Drug Product Quality Attributes.
    Butreddy A; Dudhipala N; Janga KY; Gaddam RP
    AAPS PharmSciTech; 2020 Sep; 21(7):252. PubMed ID: 32885357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Formulation Development Approach to Identify and Select Stable Ultra-High-Concentration Monoclonal Antibody Formulations With Reduced Viscosities.
    Whitaker N; Xiong J; Pace SE; Kumar V; Middaugh CR; Joshi SB; Volkin DB
    J Pharm Sci; 2017 Nov; 106(11):3230-3241. PubMed ID: 28668340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a Predictive Regression Model for Estimating Hold-Up Volume for Biologic Drug Product Presentations.
    Mehta SB; Subramanian S; Brown R; D'Mello R; Brisbane C; Roy S
    PDA J Pharm Sci Technol; 2020; 74(3):290-300. PubMed ID: 31732689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introducing the Alba
    Chillon A; Pace A; Zuccato D
    PDA J Pharm Sci Technol; 2018; 72(4):382-392. PubMed ID: 29853611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Risk-Based Approach to Evaluate and Control Elemental Impurities in Therapeutic Proteins.
    Luo Y; Sekhar C; Lee H; Fujimori K; Ronk M; Semin D; Nashed-Samuel Y
    J Pharm Sci; 2020 Nov; 109(11):3378-3385. PubMed ID: 32745562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current perspectives on stability of protein drug products during formulation, fill and finish operations.
    Rathore N; Rajan RS
    Biotechnol Prog; 2008; 24(3):504-14. PubMed ID: 18484778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering.
    Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE
    Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.